To investigate relationships between changes in weight and changes in cardiovascular risk factors in adults, taking intentionality of weight loss into account. DESIGN: Longitudinal study in middle-aged French subjects from the SU.VI.MAX cohort. SUBJECTS: A total of 1773 men (body mass index (BMI) 25.4 AE 3.1 kg=m 2 , mean AE s.d) and 2316 women (BMI 23.3 AE 3.8 kg=m 2 ) aged 45 y and over at baseline. MEASURMENTS: Weight, height, blood pressure, serum total cholesterol and fasting blood glucose were measured at baseline and after a 2 y follow-up. Self-reported dieting in order to lose weight, smoking status, leisure-time physical activity, health events and current treatments were assessed through questionnaires. RESULTS: In multivariate analyses, weight change was positively associated with changes in systolic and diastolic blood pressure (P ¼ 0.0002 in women, P ¼ 0.0001 in men) and with changes in serum total cholesterol (P ¼ 0.008 in women, P ¼ 0.02 in men), after adjustment for age, baseline level of each cardiovascular risk factor and current treatments. For example, in men, a weight loss of 5 kg was associated with a decrease of 2.5 mmHg in systolic blood pressure and of 1.5 mmHg in diastolic blood pressure. Taking into account self-reported dieting did not modify these associations. CONCLUSIONS: In both genders, systolic and diastolic blood pressure and serum cholesterol increased with weight gain and decreased with weight loss, independently of the intentionality to lose weight. At the population level, modest weight loss may have a substantial impact on cardiovascular risk, and preventing even modest weight gain in adults is an important goal in terms of public health.
Introduction
It is well established that increased body weight is associated with major cardiovascular risk factors including high blood pressure, raised cholesterol concentrations and impaired glucose tolerance. 1 Prospective cohort studies have also shown that weight gain through adulthood is associated with an increased risk for hypertension 2 and type 2 diabetes. 3, 4 The escalating obesity rate in many countries is expected to have a deleterious impact on the cardiovascular risk profile over time. 1 Results from a number of clinical trials in overweight or obese subjects indicate that weight loss, even modest weight loss of up to 10% of initial body weight, reduces blood pressure and cholesterol concentrations and improves glycaemic control. 5 -7 For a better understanding of the relationship between weight changes and morbidity or mortality in population studies, the importance of the distinction between intentional and unintentional weight loss is recognized. 8 This is important as unintentional weight loss resulting from underlying illness may artificially lead to a positive association of weight loss with disease outcomes. 9 The effects of weight change while controlling for unintentional weight loss have been mainly investigated in relation to mortality. 10 -14 The results of the only study investigating the associations of changes in weight with changes in selected cardiovascular risk factors in men taking intentionality of weight loss into account were inconclusive. 14 The aim of the present study was to further investigate the associations of changes in body weight with changes in cardiovascular risk factors in middle-aged adults of both gender. We used longitudinal data from the SU.VI.MAX study to examine the relationships of weight change over a 2 y period with changes in blood pressure, total cholesterol and blood glucose concentrations, taking intentionality of weight loss and pre-existing illness into account.
Subjects and methods

Subjects
Subjects were participants who volunteered to the SU.VI.-MAX ('SUpplémentation en VItamines et Minéraux AntioXydants') study. The study design, population and methods were previously described in detail. 15 Briefly, the SU.VI.MAX study is a randomized double-blind, placebo-controlled, prevention trial primarily designed to test the efficacy of a daily supplementation with antioxidant vitamins (E, C and betacarotene) and minerals (selenium and zinc) at nutritional doses, in reducing the incidence of cardiovascular disease and cancer. Another objective of the study is to contribute to a better understanding of the relationships between nutrition and health, by constituting a large database on indicators of nutritional status and health events in a national French sample of adult subjects. Among the 12 735 subjects included in October 1994 with a planned follow-up of 8 y, two-thirds were women aged 35 -60 y and one third were men aged 45 -60 y. All subjects gave their informed written consent to the study which was approved by the ad hoc ethical committee (CCPPRB no. 706 Paris-Cochin, France).
Participants undergo a yearly visit with every other year either blood sampling (from 1995 onward) or clinical examination (from 1996 onward). In the present study, only subjects who had available data for the two blood samplings and two clinical examinations were included. Body weight, height and blood pressure were simultaneously measured in 1996 and 1998, whereas biochemical measurements were performed in 1995 and 1997. Subjects with current or past history of cancer, coronary heart disease or stroke, chronic digestive disease, as well as pregnant women and subjects receiving treatment for thyroid disorders, upon entry or at any time during follow-up, were excluded. In order to have the same age range in both gender, women younger than 45 y were excluded. In total, 2316 women and 1773 men were included in the present analyses.
Body weight, height and blood pressure measurements Weight was measured with an electronic scale (Seca, Germany) with subjects in indoor clothing and no shoes. Height was measured in the same conditions to the nearest 0.5 cm with a wall-mounted stadiometer. BMI was calculated as weight divided by height squared (kg=m 2 ). Systolic and diastolic blood pressure were measured using a standard mercury sphygmomanometer in subjects who had been lying down for 10 min. If systolic pressure was above 160 mmHg or diastolic pressure above 100 mmHg, blood pressure was remeasured after another 5 min rest. The lowest measure was kept as the reference blood pressure.
Biochemical measurements
Plasma glucose and serum total cholesterol concentrations were measured with a DAX Technicon analyser using oxydase enzymatic methods (Bayer Diagnostic 1 ), on blood samples collected after a 12 h fast. Laboratory quality control procedures included analysis of serum from standard pools with each run and international standards. All biochemical measurements were centralized and performed in a single laboratory (Institut inter-Régional pour la Santé, Tours, France).
Health and physical activity questionnaires
In the SU.VI.MAX study, subjects are invited to report monthly, in lay language, all health events and treatments received during the previous month. These health questionnaires are transmitted to the data coordinating centre (INSERM U.557, Paris) by paper, internet or telephone using the French Telematic Network Minitel and an electronic device specifically designed for the SU.VI.MAX study. Subjects who reported that they started a diet to lose weight during the study period were defined as dieters. Medical treatments were also reported via monthly health questionnaires. Health events, treatments received, smoking and dieting status were validated and coded by trained physicians. Leisure-time physical activity was assessed in 1998, using a French self-administered version of the Modifiable Activity Questionnaire. 16 Past-year leisure-time physical activity was expressed in Metabolic Equivalent Task (MET)-hours per week, after multiplying the number of hours per week of each leisure activity reported by its estimated metabolic cost expressed in multiple of resting metabolic rate (MET). 17 
Statistical analyses
Weight change over the 2 y study period was defined as the difference between the subject's weight in 1998 minus weight in 1996. Relative weight change was defined as the difference between the subject's weight in 1998 minus weight in 1996 divided by weight in 1996. We similarly calculated the changes in cardiovascular risk factors under study (systolic and diastolic blood pressure, serum total cholesterol, fasting blood glucose).
Associations between changes in body weight and changes in cardiovascular risk factors were assessed using Weight change and cardiovascular risk factors S Czernichow et al multiple linear regression analysis with adjustment for age, baseline levels of blood pressure, serum total cholesterol, fasting blood glucose and use of hypoglycaemic agents, antihypertensive or lipid lowering drugs where appropriate. Analyses were performed separately for each gender. Stratified analyses were performed to assess the effect modification of dieting or initial body mass index (BMI) on the association between changes in body weight and changes in cardiovascular risk factors. Residual analyses and Durbin -Watson statistics were used to assess the validity of regression test and the good fit of linear model.
All statistical analyses were performed using SAS software (SAS Institute, Cary, NC, USA). Statistical significance was judged at a < 0.05.
Results
The proportion of men with an initial BMI ! 25 kg=m 2 was twice that of women (Table 1 ). Mean weight change over 2 y was similar in women and in men ( Table 2 ). More women than men declared being on a diet during follow-up. Mean systolic blood pressure increased, whereas mean diastolic blood pressure, serum total cholesterol and fasting blood glucose decreased during the study period.
Weight change was statistically significantly associated in both gender with changes in systolic and diastolic blood pressure (P ¼ 0.0002 in women, P ¼ 0.0001 in men) and changes in serum total cholesterol (P ¼ 0.008 in women, P ¼ 0.02 in men), after adjustment for age, baseline level of each cardiovascular risk factor and current treatment (Table  3) . Further adjustment for leisure physical activity, quitting smoking during the study period or use of antidepressant drugs did not modify these associations, and therefore these factors were not retained in the final models. The models indicate that, for example in men, a weight loss of 5 kg is associated with a decrease of 2.5 mmHg in systolic blood pressure and 1.5 mmHg in diastolic blood pressure (Table 3) . Using classes of weight changes, data on Figures 1 and 2 indicate that systolic blood pressure increased least and diastolic blood pressure decreased most in subjects that had lost more than 2 kg in both gender. The association between change in weight and change in systolic blood pressure ( Figure 1 ) and diastolic blood pressure (Figure 2 For changes in blood pressure, as well as for changes in serum total cholesterol, no effect modification of initial BMI or dieting was observed. In men, an inverse association between weight change and change in fasting blood glucose was seen only in those with an initial BMI < 25 kg=m 2 in dieters (b ¼ 7 0.004, P ¼ 0.7) and non-dieters (b ¼ 7 0.003, P ¼ 0.5), but also in non-dieters with a BMI ! 25 kg=m Weight change and cardiovascular risk factors S Czernichow et al
Discussion
In this longitudinal study in middle-aged French men and women, weight change was positively associated with changes in atherogenic traits such as blood pressure and serum cholesterol concentrations. One strength of this work is that weight and height were measured, whereas they were self-reported in many previous studies. 10 -12 It has been shown that self-reported vs measured weight and height may lead to misclassification for body weight status. 18 We also excluded from the analyses all subjects with conditions known to result in an involuntary change of weight, and adjusted in multivariate analyses for current treatments for high blood pressure, hyperlipidaemia or hyperglycaemia. We attempted to distinguish subjects who intended to lose weight from those who did not, by collecting data on dieting for the purpose of losing weight during the period where weight change was assessed. It should also be noted that, during follow-up of the SU.VI.-MAX study, subjects with abnormal biological or blood pressure measurements were kept informed of such results and advised to consult their general practitioners. The increased percentage of medication used during follow-up compared to baseline may thus represent a beneficial effect of the bio-clinical screening in participants.
A potential limitation of the present study is the shift in the time frame of the SU.VI.MAX study where participants undergo a yearly visit with every other year either clinical examination or blood sampling. Therefore, the measurement of the biochemical cardiovascular risk factors (serum total cholesterol and fasting blood glucose) was performed in 1995 and 1997, whereas body weight, height and blood pressure were simultaneously measured in 1996 and 2 y after in 1998. This shift has probably led to an underestimation of the observed relationship between changes in cholesterol and weight and may explain, at least in part, the lack of a significant association (before or after any adjustment) between changes in weight and changes in fasting blood glucose in our total sample.
Our results confirm previous reports in various populations documenting, positive associations between changes in weight and changes in systolic and=or diastolic blood pressure and in cholesterol concentrations. 14,19 -26 Recently, in a Weight change and cardiovascular risk factors S Czernichow et al study in a random sample of Mexican American women (n ¼ 321) and men (n ¼ 218) followed up for 5 y, relative changes in weight were positively associated with relative changes in systolic and diastolic blood pressure, and with changes in cholesterol levels. 26 No association was found with relative change in fasting blood glucose. 26 Similarly, in 867 male volunteers enrolled in the Normative Aging Study 25 and followed up for 15 y, changes in BMI were positively associated with changes in cholesterol concentrations but not with changes in fasting blood glucose, which is in agreement with our results. In the present study, the association between changes in weight and changes in systolic and diastolic blood pressure was stronger in men than in women. This is in accordance with previous reports from the Framingham study. 19 Associations between abdominal fat accumulation and blood pressure are well known. 27 One explanation for the difference in blood pressure changes between genders might be that body weight changes were associated with different effects on body fat distribution in men compared to women.
The intentionality of weight loss is now considered as an essential element in the understanding of the relationship between weight change and morbidity or mortality. 8, 28 Unintentional weight loss can be considered as a marker for underlying illness. 29 The few observational studies that have assessed intentionality of weight loss were mainly focused on mortality end-points. 10 -14 Despite the well-established reduction in cardiovascular risk factors that occur with weight loss, it should be noted that only one of these large studies showed an association between voluntary weight loss and reduced cardiovascular mortality. 13 We did not find a significant effect modification of selfreported dieting on the relation between weight change and changes in blood pressure or serum cholesterol during the 2 y follow-up. However, participants were free to mention dieting in the monthly health questionnaires and thus not everyone may have done so. Such an information bias may have led to misclassification of dieters in the non-dieting group. We also lacked information on the duration and type or composition of diets that were followed. To our knowledge, relationships between changes in weight and changes in blood pressure and cholesterol levels according to selfreported dieting status were assessed in only one previous prospective study. 14 In the Israeli Heart Study, those reporting dieting in order to lose weight, increased their mean blood pressure, over a 5 y follow-up regardless of weight change, whereas for those 'dieting for health reasons', weight loss ! 5 kg was accompanied by a small reduction in systolic and diastolic blood pressure. No noticeable difference between dieting groups was observed for changes in serum cholesterol.
The effect modification by initial BMI or dieting we have observed in the relation between weight change and changes in fasting blood glucose was weak and difficult to explain. It may well be due to random fluctuation in this sample with a majority of healthy subjects. Data from the Israeli Heart Study reported by Yaari et al, 14 together with our findings, emphasize the complexity of the relationships between weight change, dieting and health outcomes. The difficulties in assessing the intentionality of weight change and to adequately control for pre-existing illness in observational studies indicate the value of interventional studies, such as the ongoing SOS study, 30, 31 designed to measure long-term changes in health outcomes that accompany intentional sustained weight loss.
In summary, in a large sample of middle-aged French men and women, weight change over time was positively associated with changes in systolic and diastolic blood pressure and with changes in serum cholesterol. These risk factors increased with weight gain and decreased with weight loss in both gender. This effect was independent of self-reported dieting, but a better methodology to assess dieting status concurrent to weight change in free-living populations is needed. Although the effects we observed were moderate in individual terms, modest weight loss through the improvement of risk factors may have a substantial impact on cardiovascular risk at the population level. Results of the present study also confirms that preventing even modest weight gain in adults is an important goal in terms of public health.
